During antibody affinity maturation, germinal center (GC) B cells cycle between affinity-driven selection in the light zone (LZ) and proliferation and somatic hypermutation in the dark zone (DZ). Although selection of GC B cells is triggered by antigen-dependent signals delivered in the LZ, DZ proliferation occurs in the absence of such signals. We show that positive selection triggered by T cell help activates the mechanistic target of rapamycin complex 1 (mTORC1), which promotes the anabolic program that supports DZ proliferation. Blocking mTORC1 prior to growth prevented clonal expansion, whereas blockade after cells reached peak size had little to no effect. Conversely, constitutively active mTORC1 led to DZ enrichment but loss of competitiveness and impaired affinity maturation. Thus, mTORC1 activation is required for fueling B cells prior to DZ proliferation rather than for allowing cell-cycle progression itself and must be regulated dynamically during cyclic re-entry to ensure efficient affinity-based selection.
Pubmed ID: 28636954 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Software package for interpreting gene expression data. Used for interpretation of a large-scale experiment by identifying pathways and processes.
View all literature mentionsThis polyclonal targets heavy chain of mouse IgG1
View all literature mentionsThis monoclonal targets mTOR
View all literature mentionsThis monoclonal targets S6 Ribosomal Protein
View all literature mentionsThis monoclonal targets 4E-BP1 (53H11) Rabbit mAb
View all literature mentionsThis monoclonal targets p70 S6 Kinase
View all literature mentionsThis monoclonal targets Akt (pan) (C67E7) Rabbit mAb
View all literature mentionsThis monoclonal targets Phospho-Akt (Ser473)
View all literature mentionsThis monoclonal targets Phospho-Akt (Thr308) (C31E5E) Rabbit mAb
View all literature mentionsThis monoclonal targets 4E-BP1, phospho (Thr37 / Thr46)
View all literature mentionsThis monoclonal targets p70 S6 Kinase, phospho (Thr389)
View all literature mentionsThis isotype control targets Trinitrophenol
View all literature mentionsThis monoclonal targets CD40
View all literature mentionsThis isotype control targets Unknown Specificity
View all literature mentionsThis monoclonal targets CD40L (CD154)
View all literature mentionsThis monoclonal targets CD35
View all literature mentionsThis monoclonal targets c-Myc (D84C12) XP Rabbit mAb
View all literature mentionsThis monoclonal targets AID
View all literature mentionsThis monoclonal targets S6 Ribosomal Protein, phospho (Ser235 / Ser236)
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets CD185
View all literature mentionsThis monoclonal targets CD184 (CXCR4)
View all literature mentionsThis monoclonal targets CD95
View all literature mentionsThis monoclonal targets CD86
View all literature mentionsThis monoclonal targets CD83
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD45R
View all literature mentionsMus musculus with name STOCK Tsc1tm1Djk/J from IMSR.
View all literature mentionsMus musculus with name B6.129(ICR)-Tg(CAG-ECFP)CK6Nagy/J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Ptprca Tg(UBC-PA-GFP)1Mnz/J from IMSR.
View all literature mentionsMus musculus with name B6.129P2(C)-Ightm2Cgn/J from IMSR.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentions